|
【结 构 式】 
|
【分子编号】40716 【品名】 【CA登记号】 |
【 分 子 式 】C44H50NO6P 【 分 子 量 】719.857902 【元素组成】C 73.42% H 7% N 1.95% O 13.34% P 4.3% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号：(III)Phosphitylation of 1D-2,4,5,6-tetra-O-benzyl-3-deoxy-myo-inositol (I) with benzyl tetraisopropylphosphorodiamidite (II) in the presence of diisopropylammonium tetrazolide produced phosphoramidite (III). Subsequent displacement of the remaining diisopropylamino group of (III) by 1-O-octadecyl-2-O-methyl-sn-glycerol (IV) gave phosphite ester (V), which was further oxidized to phosphate (VI) using tert-butyl hydroperoxide. Finally, removal of the benzyl protecting groups of (VI) was achieved by catalytic hydrogenation over Pearlman's catalyst.
| 【1】 Qiao, L.; Nan, F.; Kunkel, M.; Gallegos, A.; Powis, G.; Kozikowski, A.P.; 3-Deoxy-D-myo-inositol 1-phosphate, 1-phosphonate, and ether lipid analogues as inhibitors of phosphatidylinositol-3-kinase signalling and cancer cell growth. J Med Chem 1998, 41, 18, 3303. |
| 【2】 Powis, G.; Qioa, L.; Kozikowski, A.P. (Georgetown University); Inhibitors of phosphatidyl myo-inositol cycle. WO 0000206 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 40714 | (1R,2S,3S,4R,6R)-2,3,4,6-tetrakis(benzyloxy)cyclohexanol | C34H36O5 | 详情 | 详情 | |
| (II) | 40715 | C13H23N2OP | 详情 | 详情 | ||
| (III) | 40716 | C44H50NO6P | 详情 | 详情 | ||
| (IV) | 40717 | (2S)-2-methoxy-3-(octadecyloxy)-1-propanol | C22H46O3 | 详情 | 详情 | |
| (V) | 40718 | benzyl (2R)-2-methoxy-3-(octadecyloxy)propyl (1R,2R,3S,4R,6R)-2,3,4,6-tetrakis(benzyloxy)cyclohexyl phosphite | C63H87O9P | 详情 | 详情 | |
| (VI) | 40719 | benzyl (2R)-2-methoxy-3-(octadecyloxy)propyl (1R,2R,3S,4R,6R)-2,3,4,6-tetrakis(benzyloxy)cyclohexyl phosphate | C63H87O10P | 详情 | 详情 |
Extended Information